271 related articles for article (PubMed ID: 6087121)
1. Human monoclonal antibodies.
Cole SP; Campling BG; Atlaw T; Kozbor D; Roder JC
Mol Cell Biochem; 1984 Jun; 62(2):109-20. PubMed ID: 6087121
[TBL] [Abstract][Full Text] [Related]
2. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
Foung SK; Perkins S; Raubitschek A; Larrick J; Lizak G; Fishwild D; Engleman EG; Grumet FC
J Immunol Methods; 1984 May; 70(1):83-90. PubMed ID: 6201562
[TBL] [Abstract][Full Text] [Related]
3. Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma.
Kozbor D; Roder JC; Chang TH; Steplewski Z; Koprowski H
Hybridoma; 1982; 1(3):323-8. PubMed ID: 6092264
[TBL] [Abstract][Full Text] [Related]
4. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
Garzelli C; Puglisi C; Falcone G
Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
[TBL] [Abstract][Full Text] [Related]
5. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
6. Generation of human anti-rubella monoclonal antibodies from human hybridomas constructed with antigen-specific Epstein-Barr virus transformed cell lines.
Hilfenhaus J; Kanzy EJ; Köhler R; Willems WR
Behring Inst Mitt; 1986 Jun; (80):31-41. PubMed ID: 3019293
[TBL] [Abstract][Full Text] [Related]
7. A human-human hybridoma producing cytotoxic antibody to HLA-B15, cross-reacting with B17, B5, B35 and B18.
Hansen T; Kolstad A; Thorsby E; Hannestad K
Tissue Antigens; 1987 May; 29(5):246-56. PubMed ID: 2821654
[TBL] [Abstract][Full Text] [Related]
8. The hybridization of EBV-immortalized human B-lymphocytes with a human-mouse heteromyeloma cell line.
Jahn S; Walper A; Grunow R; Heym S; Volk HD; von Baehr R
Allerg Immunol (Leipz); 1990; 36(4):359-65. PubMed ID: 1965878
[TBL] [Abstract][Full Text] [Related]
9. The production of monoclonal antibodies from human lymphocytes.
Kozbor D; Roder JC
Immunol Today; 1983 Mar; 4(3):72-9. PubMed ID: 25291284
[TBL] [Abstract][Full Text] [Related]
10. Establishment of hybridoma secreting human monoclonal antibody against hepatitis B virus surface antigen.
Ichimori Y; Harada K; Hitotsumachi S; Tsukamoto K
Biochem Biophys Res Commun; 1987 Feb; 142(3):805-12. PubMed ID: 3030301
[TBL] [Abstract][Full Text] [Related]
11. The production of human monoclonal autoantibodies from patients with rheumatoid arthritis by the EBV-hybridoma technique.
Haskard DO; Archer JR
J Immunol Methods; 1984 Nov; 74(2):361-7. PubMed ID: 6094669
[TBL] [Abstract][Full Text] [Related]
12. Further analyses of epitopes for human monoclonal anti-basement membrane zone antibodies produced by stable human hybridoma cell lines constructed with Epstein-Barr virus transformants.
Hashimoto T; Amagai M; Ebihara T; Gamou S; Shimizu N; Tsubata T; Hasegawa A; Miki K; Nishikawa T
J Invest Dermatol; 1993 Mar; 100(3):310-5. PubMed ID: 7680057
[TBL] [Abstract][Full Text] [Related]
13. An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies.
Yu X; McGraw PA; House FS; Crowe JE
J Immunol Methods; 2008 Jul; 336(2):142-51. PubMed ID: 18514220
[TBL] [Abstract][Full Text] [Related]
14. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
[TBL] [Abstract][Full Text] [Related]
15. Screening of antigen-specific antibody-secreting cells.
Kishi H; Jin A; Ozawa T; Tajiri K; Obata T; Muraguchi A
Methods Mol Biol; 2012; 853():141-50. PubMed ID: 22323145
[TBL] [Abstract][Full Text] [Related]
16. Production and characterization of human-human and human-mouse hybridomas secreting Rh(D)-specific monoclonal antibodies.
MacDonald G; Primrose S; Biggins K; Bowman JM; Berczi I; Friesen AD; Sehon AH
Scand J Immunol; 1987 May; 25(5):477-83. PubMed ID: 3035706
[TBL] [Abstract][Full Text] [Related]
17. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization.
Buchacher A; Predl R; Strutzenberger K; Steinfellner W; Trkola A; Purtscher M; Gruber G; Tauer C; Steindl F; Jungbauer A
AIDS Res Hum Retroviruses; 1994 Apr; 10(4):359-69. PubMed ID: 7520721
[TBL] [Abstract][Full Text] [Related]
18. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.
Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J
Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436
[TBL] [Abstract][Full Text] [Related]
19. Use of Epstein-Barr virus-transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas.
Chiorazzi N; Wasserman RL; Kunkel HG
J Exp Med; 1982 Sep; 156(3):930-5. PubMed ID: 6286839
[TBL] [Abstract][Full Text] [Related]
20. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
